Results 111 to 120 of about 820,680 (203)

Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells. [PDF]

J Clin Invest
Wu Y, Tian L, Pugel A, Alimohammadi R, Cheng Q, Cui W, Nishimura MI, Ball LE, Lin CW, Mehrotra S, Kraft AS, Yu XZ.   +11 more
europepmc   +1 more source

OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives. [PDF]

Front Immunol
Luo Y, Li J, Li L, Qin B, Zhou R, Tang Y.   +5 more
europepmc   +1 more source

Neurotrophin System Alterations Associated with Neurotoxicity Accompanied by Carotid Artery Diseases-A Systematic Review. [PDF]

Int J Mol Sci
Milosavljevic J, Mitrovic M, Selakovic D, Kumburovic D, Sreckovic M, Randjelovic S, Rosic S, Cpajak M, Jovicic N, Rosic G.   +9 more
europepmc   +1 more source

Mature tertiary lymphoid structures tumor microenvironment-based risk model to assess patients with pancreatic ductal adenocarcinoma. [PDF]

Transl Cancer Res
Gu Z, He C, Cheng S, Su Q, Yu J.
europepmc   +1 more source

Adult Neurogenesis in Neurodegenerative Diseases: Mechanisms of Dysregulation in Alzheimer's and Parkinson's Disease. [PDF]

Int J Mol Sci
Dębiec M, Rojek M.
europepmc   +1 more source

Emerging novel methodologies to understand and strategically target long-lived plasma cells in vaccine design to induce durable immunity. [PDF]

Front Immunol
Cusimano G, Staupe RP, Sullivan NL.
europepmc   +1 more source

Anti-thymocyte globulin-resistant CD4⁺ memory T cells contribute to haplo-fever after allogeneic hematopoietic stem cell transplantation. [PDF]

Blood Sci
Huang H, Lu T, Duan H, Huang J, Gu Q, Cheng H, Pan Z, Hu X.   +7 more
europepmc   +1 more source

B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma. [PDF]

Cancer Immunol Immunother
Liljeström V, Farrajota Neves da Silva P, Bark R, Elliot A, Marklund L, Margolin G, Kumlien Georén S, Cardell LO, Piersiala K.   +8 more
europepmc   +1 more source